Journal of Medical Economics, Volume 18, Issue 12 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 18, Issue 12 (2015)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Volume 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Professional

Editorial
The status of modeled claims
Paul C. Langley
Pages: 991-992
Published online: 07 Nov 2015
AbstractforThe status of modeled claims | Full Text | References | PDF (40.5 KB)
  • 664 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Validation of modeled pharmacoeconomic claims in formulary submissions
Paul C. Langley
Pages: 993-999
Published online: 07 Nov 2015
AbstractforValidation of modeled pharmacoeconomic claims in formulary submissions | Full Text | References | PDF (80.8 KB)
  • 901 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Validating pharmaceutical product claims: questions a formulary committee should ask
Jon C. Schommer, Angeline M. Carlson & Taeho Greg Rhee
Pages: 1000-1006
Published online: 07 Nov 2015
AbstractforValidating pharmaceutical product claims: questions a formulary committee should ask | Full Text | References | PDF (85.4 KB)
  • 3058 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Predictive validation of modeled health technology assessment claims: lessons from NICE
Jonathan Belsey
Pages: 1007-1012
Published online: 07 Nov 2015
AbstractforPredictive validation of modeled health technology assessment claims: lessons from NICE | Full Text | References | PDF (78.4 KB)
  • 871 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Using ‘big data’ to validate claims made in the pharmaceutical approval process
Thomas Wasser, Kevin Haynes, John Barron & Mark Cziraky
Pages: 1013-1019
Published online: 07 Nov 2015
AbstractforUsing ‘big data’ to validate claims made in the pharmaceutical approval process | Full Text | References | PDF (78.9 KB)
  • 2470 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Obesity

Article
Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States
Qian Li, Steven W. Blume, Joanna C. Huang, Mette Hammer & Michael L. Ganz
Pages: 1020-1028
Published online: 02 Jul 2015
AbstractforPrevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States | Full Text | References | PDF (460.8 KB) | Supplemental
  • 9612 Views
  • 45 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Letter
A new angle for glp-1 receptor agonist: the medical economics argument
Editorial on: Huetson P, Palmer JL, Levorsen A, et al. Cost-effectiveness of the once-daily glp-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. J Med Econ 2015: 1–13 [Epub ahead of print]
Willy Marcos Valencia & Hermes Jose Florez
Pages: 1029-1031
Published online: 06 Jul 2015
AbstractforA new angle for glp-1 receptor agonist: the medical economics argument | Full Text | References | PDF (56.3 KB)
  • 1542 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Cardiovascular event costs in patients with Type 2 diabetes mellitus
Stephen S. Johnston, John J. Sheehan, Manan Shah, Katherine Cappell, Nicole Princic, David Smith & Iftekhar Kalsekar
Pages: 1032-1040
Published online: 26 Aug 2015
AbstractforCardiovascular event costs in patients with Type 2 diabetes mellitus | Full Text | References | PDF (193.5 KB)
  • 840 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy
Joseph F. Dasta, Dominic Pilon, Samir H. Mody, Jessica Lopatto, François Laliberté, Guillaume Germain, Brahim K. Bookhart, Patrick Lefebvre & Edith A. Nutescu
Pages: 1041-1049
Published online: 26 Aug 2015
AbstractforDaily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy | Full Text | References | PDF (176.4 KB)
  • 398 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Article
Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK
G. Muduma, I. Odeyemi & R. F. Pollock
Pages: 1050-1059
Published online: 26 Aug 2015
AbstractforEvaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK | Full Text | References | PDF (260 KB)
  • 900 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Nephrology

Article
Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs
Francis Vekeman, Matthew Magestro, Paul Karner, Mei Sheng Duh, Timothy Nichols, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani & Bernard A. Zonnenberg
Pages: 1060-1070
Published online: 26 Aug 2015
AbstractforKidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs | Full Text | References | PDF (252.9 KB)
  • 1537 Views
  • 27 CrossRef citations
  • 0Altmetric
Free Access

Pharmaceutical

Editorial
A long war begins: biosimilars versus patented biologics
François Bocquet & Pascal Paubel
Pages: 1071-1073
Published online: 27 Jul 2015
First Page PreviewforA long war begins: biosimilars versus patented biologics | Full Text | References | PDF (58.7 KB)
  • 1514 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users
William H. Olson, Yi-Wen Ma, Concetta Crivera, Jeff Schein, Patrick Lefebvre, François Laliberté, Katherine Dea, Guillaume Germain & Scott M. Lynch
Pages: 1074-1084
Published online: 20 Aug 2015
AbstractforEconomic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users | Full Text | References | PDF (228.4 KB)
  • 448 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada
Emily Dorman, Anuraag R. Kansal & Sujata Sarda
Pages: 1085-1091
Published online: 20 Aug 2015
AbstractforThe budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada | Full Text | References | PDF (210.9 KB)
  • 650 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Infection

Article
Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting
V. Ektare, A. Khachatryan, M. Xue, M. Dunne, K. Johnson & J. Stephens
Pages: 1092-1101
Published online: 20 Aug 2015
AbstractforAssessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting | Full Text | References | PDF (505.4 KB)
  • 4197 Views
  • 47 CrossRef citations
  • 0Altmetric
Free Access

Corrigendum

Article
Corrigendum to: Low-intensity pulsed ultrasound (LIPUS) can decrease the economic burden of fracture non-union
Page: 1102
Published online: 28 Aug 2015
CitationforCorrigendum to: Low-intensity pulsed ultrasound (LIPUS) can decrease the economic burden of fracture non-union | Full Text | PDF (29.3 KB)
  • 222 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles